ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pfizer Initiates Study of Vupanorsen
November 12, 2020Ionis Pharmaceuticals and its wholly owned subsidiary Akcea Therapeutics announced Pfizer has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in statin-treated patients with elevated non-high-density lipoprotein cholesterol (non-HDL-C) and .. -
Akcea Therapeutics Appoints CMO
July 10, 2020William Andrews will lead medical, clinical and regulatory functions in support of the company's two commercial-stage products. -
Final NICE guidance issued for Akcea’s Tegsedi
May 28, 2019Akcea Therapeutics UK has announced that the National Institute for Health and Care Excellence (NICE) has published a final guideline for its nerve damage drug, Tegsedi (inotersen). -
Akcea lays off 10% of staff following volanesorsen rejection
September 10, 2018Akcea had built its headcount up to 270 in anticipation of bringing volanesorsen to market.
Pharma Sources Insight January 2025
